December 11, 2017
Strict e-cigarette policies are meant to keep non-smokers from smoking. But they may also be preventing many smokers from quitting
Regulatory strategies on electronic cigarettes vary from country to country. The International Tobacco Control Policy Evaluation Project, led by Dr. Geoffrey Fong, explored how different regulatory environments might influence the effectiveness of e-cigarettes for smoking cessation. This research could be used to help shape e-cigarette control policies that minimize the potential health risks and recognize the potential benefits of e-cigarettes as a smoking cessation aid.
October 24, 2017
Brain tumours resulting from the spread of cancer from its primary location, known as brain metastases (BM), are the most common form of brain tumours in adults. A team of Ontario-based researchers recently identified two genes that seem to play a central role in BM in lung cancer patients – findings that could lead to improved biomarkers and treatments for BM.
In a study published in the journal Acta Neuropatologica, Mohini Singh and her collaborators focused on a class of cells they have termed Brain Metastases Initiating Cells (BMICs), which leave the primary site of cancer and migrate to the brain.
Singh, a biochemistry PhD candidate in the lab of Dr. Sheila Singh at McMaster University, explains the approach the team took to study these cells. “There was a lack of preclinical models that we could use to comprehensively study BMICs and understand the mechanisms behind them. To conduct our study we used brain metastases from lung cancer patients, which we cultured in conditions to enrich for BMICs, and then transplanted them into mice. This method allowed us to study BMICs within a living host, which provides a more accurate representation of the development of brain metastasis in humans.”
The researchers performed in vitro and in vivo RNA interference screens utilizing their unique BM models, and found two genes that were essential to the regulation of BMICs: SPOCK1 and TWIST2. “We discovered that SPOCK1 is a regulator of self-renewal in BMICs, playing a role in the initiation of lung tumours and their metastasis to the brain,” explains Singh. Furthermore, the results were clinically relevant. “Increased SPOCK1 expression was seen in lung cancer biopsies of patients with known brain metastases, and was correlated with poor survival.” Through protein-protein interaction mapping the researchers also identified new pathway interactors of the two genes that could be used as novel targets in treatment of BM in lung cancer patients.
“Identifying these two genes could be of great use in improving the treatment of lung cancer. In the future we could predict those patients who are most at risk of developing a brain metastasis and use drugs to target BMIC regulatory genes such as SPOCK1 and TWIST2 to destroy the initiating cells and to block the spread,” says Singh. “This would result in keeping the lung cancer locally controlled and therefore more treatable.”
OICR funding was used to establish this study with further significant funding coming from the Canadian Cancer Society and the Brain Canada Studentship.
August 17, 2017
Research from McMaster University has identified new regulators of brain metastases in patients with lung cancer.
These regulators are the genes called SPOCK1 and TWIST2.
May 31, 2016
For many years, smoking was considered a sophisticated and glamorous pastime advertised to millions as a source of relaxation and freedom. But today, in the face of decades of research showing the harmful short and long-term side effects of smoking, including cancer and lung disease, that perception has almost entirely disappeared.
Yet many people continue to smoke. Almost 15 per cent of Canadians (more than four million people) were active smokers in 2013, with the majority of smokers reporting that they smoked daily. Tobacco use is the leading cause of cancer and cancer deaths in the world and it contributes to many other serious health conditions. According to the World Health Organization (WHO), tobacco kills approximately six million people per year globally. Preventing the use of tobacco and helping users quit are the important first steps in a long-term effort to ensure fewer people develop and die from lung cancer and other related diseases.
For more information on OICR's research, careers, events and education, visit our corporate website: OICR.ON.CA